Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial

BACKGROUND: Cognitive impairment affects 50%–75% of people with secondary progressive multiple sclerosis (PwSPMS). Improving our ability to predict cognitive decline may facilitate earlier intervention. OBJECTIVE: The main aim of this study was to assess the relationship between longitudinal changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Thomas, Tur, Carmen, Eshaghi, Arman, Doshi, Anisha, Chan, Dennis, Binks, Sophie, Wellington, Henny, Heslegrave, Amanda, Zetterberg, Henrik, Chataway, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493411/
https://www.ncbi.nlm.nih.gov/pubmed/35946107
http://dx.doi.org/10.1177/13524585221114441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493411/
https://www.ncbi.nlm.nih.gov/pubmed/35946107
http://dx.doi.org/10.1177/13524585221114441

Ejemplares similares